Back
Check Point Software Technologies Ltd. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Sell
42
CHKP
Check Point Software Technologies Ltd.
Last Price:
$190.48
Seasonality Move:
10.24%
Buy
53
VKTX
Viking Therapeutics, Inc.
Last Price:
$37.52
Seasonality Move:
78.5%
Sell
42
Check Point Software Technologies Ltd. (CHKP)
is a Sell
Is Check Point Software Technologies Ltd. a Buy, Sell or Hold?
-
The current Check Point Software Technologies Ltd. [CHKP] share price is $193.06. The Score for CHKP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CHKP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Viking Therapeutics, Inc. (VKTX)
is a Buy
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $38.55. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHKP Stock Price Chart
What is Check Point Software Technologies Ltd.'s stock price today?
-
The Check Point Software Technologies Ltd. share price today is $193.06Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHKP is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $38.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight selling pressure.
CHKP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 51.72 | Buy |
| Chaikin Money Flow: | -1128611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (186.41 - 198.69) | Buy |
| Bollinger Bands (100): | (186.33 - 205.65) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.28 | Buy |
| Relative Strength Index (14 RSI): | 58.65 | Buy |
| Chaikin Money Flow: | -825700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.92 - 38.78) | Buy |
| Bollinger Bands (100): | (27.31 - 37.37) | Buy |
CHKP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 188.91 | Buy |
| 20-day SMA: | 191.99 | Buy |
| 50-day SMA: | 195.17 | Sell |
| 200-day SMA: | 208.66 | Sell |
| 8-day EMA: | 190.54 | Buy |
| 20-day EMA: | 191.13 | Buy |
| 50-day EMA: | 193.91 | Sell |
| 200-day EMA: | 199.83 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.19 | Buy |
| 20-day SMA: | 36.94 | Buy |
| 50-day SMA: | 34.59 | Buy |
| 200-day SMA: | 29.8 | Buy |
| 8-day EMA: | 36.24 | Buy |
| 20-day EMA: | 30.5 | Buy |
| 50-day EMA: | 18.84 | Buy |
| 200-day EMA: | 6.07 | Buy |
Check Point Software Technologies Ltd. Earnings Growth & CHKP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.18 per share, and a decrease next year of $0.71 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Check Point Software Technologies Ltd. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||